Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
LifeTech Scientific Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
LifeTech Scientific 'nin toplam hissedar özsermayesi CN¥3.3B ve toplam borcu ise CN¥0.0, bu da borç/özsermaye oranını 0% değerine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥4.7B ve CN¥1.4B şeklindedir. LifeTech Scientific 'nin FVÖK'ü CN¥328.5M olup, faiz karşılama oranı -27.2 dur. CN¥1.2B tutarında nakit ve kısa vadeli yatırımları vardır.
Anahtar bilgiler
2.9%
Borç/özkaynak oranı
CN¥99.00m
Borç
| Faiz karşılama oranı | -16x |
| Nakit | CN¥1.04b |
| Eşitlik | CN¥3.39b |
| Toplam yükümlülükler | CN¥1.43b |
| Toplam varlıklar | CN¥4.82b |
Son finansal sağlık güncellemeleri
Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20
LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Recent updates
Some Confidence Is Lacking In LifeTech Scientific Corporation's (HKG:1302) P/E
Jul 05LifeTech Scientific's (HKG:1302) Soft Earnings Are Actually Better Than They Appear
Apr 25What LifeTech Scientific Corporation's (HKG:1302) P/E Is Not Telling You
Dec 25Returns On Capital At LifeTech Scientific (HKG:1302) Have Stalled
Nov 28At HK$2.37, Is LifeTech Scientific Corporation (HKG:1302) Worth Looking At Closely?
Nov 03Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
Aug 17Is There Now An Opportunity In LifeTech Scientific Corporation (HKG:1302)?
Jul 18Investors Met With Slowing Returns on Capital At LifeTech Scientific (HKG:1302)
May 05Here's What To Make Of LifeTech Scientific's (HKG:1302) Decelerating Rates Of Return
Oct 14There's Been No Shortage Of Growth Recently For LifeTech Scientific's (HKG:1302) Returns On Capital
Jul 15Does LifeTech Scientific (HKG:1302) Deserve A Spot On Your Watchlist?
Jun 30A Look At The Fair Value Of LifeTech Scientific Corporation (HKG:1302)
Jun 15Returns At LifeTech Scientific (HKG:1302) Are On The Way Up
Apr 03Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
Mar 15Is LifeTech Scientific Corporation (HKG:1302) Potentially Undervalued?
Jan 22Some Investors May Be Worried About LifeTech Scientific's (HKG:1302) Returns On Capital
Dec 19Here's Why I Think LifeTech Scientific (HKG:1302) Might Deserve Your Attention Today
Dec 06Is LifeTech Scientific (HKG:1302) A Risky Investment?
Nov 20An Intrinsic Calculation For LifeTech Scientific Corporation (HKG:1302) Suggests It's 34% Undervalued
Oct 12The Returns On Capital At LifeTech Scientific (HKG:1302) Don't Inspire Confidence
Sep 13Should You Be Adding LifeTech Scientific (HKG:1302) To Your Watchlist Today?
Aug 28What Is LifeTech Scientific Corporation's (HKG:1302) Share Price Doing?
Aug 13LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business
Jun 08Here's Why I Think LifeTech Scientific (HKG:1302) Is An Interesting Stock
May 26Should You Investigate LifeTech Scientific Corporation (HKG:1302) At HK$4.14?
May 11LifeTech Scientific (HKG:1302) Could Easily Take On More Debt
Mar 31Shareholders Are Thrilled That The LifeTech Scientific (HKG:1302) Share Price Increased 274%
Feb 21Do Insiders Own Lots Of Shares In LifeTech Scientific Corporation (HKG:1302)?
Jan 26Does LifeTech Scientific's (HKG:1302) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 13
Are Strong Financial Prospects The Force That Is Driving The Momentum In LifeTech Scientific Corporation's HKG:1302) Stock?
Nov 25Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 1302's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥826.5M).
Uzun Vadeli Yükümlülükler: 1302's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥602.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 1302 has more cash than its total debt.
Borcun Azaltılması: 1302's debt to equity ratio has reduced from 22.7% to 2.9% over the past 5 years.
Borç Kapsamı: 1302's debt is well covered by operating cash flow (300.6%).
Faiz Kapsamı: 1302 earns more interest than it pays, so coverage of interest payments is not a concern.